SCHEMBL2740552

SCHEMBL2740552

O=C(c1ccc2c(c1)C1(CC1)CC(c1cc(Cl)ccc1F)N2)N1CCOCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAG1 P54619 2/20 0.71
PRKAA1 Q13131 2/20 0.71
PRKAB1 Q9Y478 2/20 0.71
PRKAB2 O43741 1/20 0.71
PRKAA2 P54646 1/20 0.71
PRKAG3 Q9UGI9 1/20 0.71
PRKAG2 Q9UGJ0 1/20 0.71
CNR1 P21554 5/20 0.45
PHGDH O43175 1/20 0.45
PKM P14618 1/20 0.42
AKR1C3 P42330 1/20 0.42
PDE4B Q07343 2/20 0.41
HPGD P15428 1/20 0.41
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
IP6K1 Q92551 2/20 0.39
IP6K3 Q96PC2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2740548 0.92 PRKAG1 (0.66) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2740533 0.83 PRKAG1 (1.00) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL47179 0.83 PRKAG1 (1.00) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL47268 0.83 PRKAG1 (0.80) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2740553 0.80 PRKAG1 (0.77) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2740559 0.79 PRKAG1 (0.93) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2740555 0.77 PRKAG1 (0.73) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2740554 0.77 PRKAG1 (0.75) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2740565 0.76 PRKAG1 (0.71) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2740564 0.74 PRKAG1 (0.71) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-01-05 US disclosed
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES GPR119, PRKAB1, PRKAG1 PRKAG1 3/4885PRKAA1 5/4885PRKAB1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.